Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ann S. Knoop"'
Autor:
Tobias Berg, Maj-Britt Jensen, Maria Rossing, Christian T. Axelsen, Iben Kümler, Lise Søndergaard, Marianne Vogsen, Ann S. Knoop, Bent Ejlertsen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: Primary metastatic breast cancer (pMBC) accounts for 5–10% of annual breast cancers with a median survival of 3–4 years, varying among subtypes. In Denmark, the incidence of breast cancer increased until 2010, followed by a stabilisat
Externí odkaz:
https://doaj.org/article/22476371f20f4d8e9fc8ba7ab74c6cb6
Publikováno v:
Research Involvement and Engagement, Vol 5, Iss 1, Pp 1-7 (2019)
Abstract Background The study is based on a national cluster randomized trial investigating the effect of electronic patient-reported outcomes (ePRO) on treatment outcomes in breast cancer patients receiving adjuvant chemotherapy. All 13 oncology dep
Externí odkaz:
https://doaj.org/article/12413e5a736848d99c08cdcd6441b327
Autor:
Annette R. Kodahl, Sidse Ehmsen, Niels Pallisgaard, Anne M. B. Jylling, Jeanette D. Jensen, Anne‐Vibeke Lænkholm, Ann S. Knoop, Henrik J. Ditzel
Publikováno v:
Molecular Oncology, Vol 12, Iss 6, Pp 925-935 (2018)
Liquid biopsies focusing on the analysis of cell‐free circulating tumor DNA (ctDNA) may have important clinical implications for personalized medicine, including early detection of cancer, therapeutic guidance, and monitoring of recurrence. Mutatio
Externí odkaz:
https://doaj.org/article/25c7104ef4c446408cd90a879f5ba181
Autor:
Anne Bruun Krøigård, Martin Jakob Larsen, Anne-Vibeke Lænkholm, Ann S Knoop, Jeanette Dupont Jensen, Martin Bak, Jan Mollenhauer, Mads Thomassen, Torben A Kruse
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0189887 (2018)
Cancer results from alterations at essential genomic sites and is characterized by uncontrolled cell proliferation, invasion and metastasis. Identification of driver genes of metastatic progression is essential, as metastases, not primary tumors, are
Externí odkaz:
https://doaj.org/article/795c5ab8d68c4c67800ecc216df41ebe
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101950 (2014)
INTRODUCTION: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast c
Externí odkaz:
https://doaj.org/article/af24c5ccfaa14349ad1dcd833633cab2
Autor:
Lænkholm AV; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Jensen MB; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Eriksen JO; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Rasmussen BB; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Knoop AS; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Buckingham W; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Ferree S; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Schaper C; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Nielsen TO; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Haffner T; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Kibøl T; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Møller Talman ML; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Bak Jylling AM; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Tabor TP; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada., Ejlertsen B; Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Mar 10; Vol. 36 (8), pp. 735-740. Date of Electronic Publication: 2018 Jan 25.